SBBP
Strongbridge Biopharma plc
Set alert
2.00 0.00 0.00%
1.96 Day range 2.05
52-week range unavailable
- Open
- 1.96
- Prev close
- 2.00
- Mkt cap
- 135.66M
- Vol
- 684.68K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.96
- High
- 2.05
- Forward P/E
- -11.76
- Beta
- 1.60
- Short ratio
- 1.40
- Inst. own
- 63.76%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2021
- 50-d avg
- 2.14
- 200-d avg
- 2.48
- 1y target
- 5.00
Valuation
P/E -3.0×
FY 2013 5y median -2.3× FY 2020
P/S 4.4×
FY 2013 5y median 5.3× FY 2020
P/B 2.1×
FY 2013 5y median 1.6× FY 2020
P/FCF -3.6×
FY 2013 5y median -2.6× FY 2020
EV/EBITDA -1.7×
FY 2013 5y median -1.4× FY 2020
EV/Sales 2.2×
FY 2013 5y median 2.8× FY 2020
FCF Yield -28.0%
FY 2013 5y median -38.1% FY 2020
Profitability
Gross Margin 92.8%
FY 2013 5y median 79.0% FY 2020
Operating Margin -140.5%
FY 2013 5y median -294.1% FY 2020
Net Margin -146.7%
FY 2013 5y median -146.7% FY 2020
ROE -68.7%
FY 2013 5y median -68.5% FY 2020
ROIC -43.1%
FY 2013 5y median -52.6% FY 2020
ROA -37.2%
FY 2013 5y median -37.2% FY 2020
Growth (YoY)
Revenue 41.5%
FY 2013 FY 2020
Operating Income 32.4%
FY 2013 FY 2020
EPS (diluted) 10.1%
FY 2013 FY 2020
Free Cash Flow 15.0%
FY 2013 FY 2020
Financial Health
Current Ratio 4.4×
FY 2013 5y median 4.4× FY 2020
Quick Ratio 4.3×
FY 2013 5y median 4.3× FY 2020
Debt / Equity 0.3×
FY 2013 5y median 0.0× FY 2020
Net Debt / EBITDA 1.8×
FY 2013 5y median 0.9× FY 2020
Interest Coverage -32.3×
FY 2013 5y median -12.3× FY 2020
Dividends
Dividend Yield 0.0%
FY 2013 5y median 0.0% FY 2020
Payout Ratio 0.0%
FY 2013 5y median 0.0% FY 2020
Annual · latest fiscal year ends 2020-12-31